Patents by Inventor Anton Haselbeck

Anton Haselbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurodegenerative disorders
    Publication number: 20100267632
    Abstract: A method of treating neurodegenerative disorders of the brain and spinal cord is disclosed. The therapeutic agent is a polyethylene glycol linked protein.
    Type: Application
    Filed: September 19, 2008
    Publication date: October 21, 2010
    Inventors: Anton Haselbeck, Frank Herting, Joerg Huwyler, Michael Jarsch
  • Erythropoietin with high specific activity
    Patent number: 7659373
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: February 9, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Treatment of neurodegenerative disorders
    Publication number: 20070072795
    Abstract: A method of treating neurodegenerative disorders of the brain and spinal cord using a novel ethropoietic agent.
    Type: Application
    Filed: September 28, 2005
    Publication date: March 29, 2007
    Inventors: Anton Haselbeck, Frank Herting, Joerg Huwyler, Michael Jarsch
  • Erythropoietin with high specific activity
    Publication number: 20050288220
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Application
    Filed: August 9, 2005
    Publication date: December 29, 2005
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Anti-selectin antibodies for prevention of multiple organ failure after polytrauma and for prevention of acute organ damage after extracorporeal blood circulation
    Publication number: 20020098183
    Abstract: Anti-selectin antibodies for reducing probability of incidence of polytraumatic events, such as organ failure.
    Type: Application
    Filed: July 26, 2001
    Publication date: July 25, 2002
    Inventors: Ulrich Martin, Anton Haselbeck, Gunther Schumacher, Man Sung Co
  • Process for the detection of compounds containing carbohydrate and a suitable reagent therefor
    Patent number: 5179004
    Abstract: For the detection of compounds containing carbohydrate the compound to be detected is reacted with a conjugate which contains a group which enables a specific binding to the substance to be detected and contains a hapten with a molecular weight from 300 to 1200, afterwards the complex formed is brought into contact with labelled antibodies directed against the hapten and the label is determined in a known way.
    Type: Grant
    Filed: December 21, 1989
    Date of Patent: January 12, 1993
    Assignee: Boehringer Mannheim GmbH
    Inventors: Anton Haselbeck, Wolfgang Hosel, Herbert von der Eltz, Edith Schickaneder